课题基金 / 基金详情

Mechanism of Pore Formation BC12 Family Proteins

Mechanism of Pore Formation BC12 Family Proteins
BC12 家族蛋白的孔隙形成机制
批准号:
6560709
负责人:
PAUL H SCHLESINGER
金额:
$26.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-02-01 至 2007-01-31

项目摘要

项目成果

PAUL H SCHLESINGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Programmed cell death is critical in growth, differentiation and homeostasis of multicellular organisms. The morphologic expression of programmed cell death, apoptosis, has a genetic basis that is clearly dependent on the BCL-2-family proteins. This family of proteins determines an early common decision point in programmed cell death. Structural studies on pro- and anti-apoptotic members of this family indicate they are related to diphtheria and colicin toxins. These proteins insert into membranes, form ion channels and participate in protein translocation. We and others have characterized the channel forming activities of the BCL-2-family members. Studies concerning these proteins have focused on the possibility that they play an important role in increased mitochondrial permeability and in release of cytochrome c. In studies preliminary to this proposal we have demonstrated that BAX forms large water filled pores in artificial liposomes. These pores undergo a concentration dependent dimer to tetramer transition, increasing their size sufficiently to activate cytochrome c transfer across the lipid bilayer. This transition occurs at nanomolar BAX concentrations, in physiologic salt and at physiologic pH without the addition of other proteins, tn this proposal we plan to study and characterize the molecular basis for formation and activation of the large BAX and BID pores, including kinetics, stoichiometry, and the effect of interaction with anti-and pro-apoptotic family members. We will also determine the effect on pore activation of the mitochondrial membrane environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of Pore Formation BC12 Family Proteins
  • 批准号:
    6696955
  • 项目类别:
  • 资助金额:
    $26.82万
  • 财政年份:
    2003
  • 负责人:
    PAUL H SCHLESINGER
  • 依托单位:
Mechanism of Pore Formation BC12 Family Proteins
  • 批准号:
    6844859
  • 项目类别:
  • 资助金额:
    $26.78万
  • 财政年份:
    2003
  • 负责人:
    PAUL H SCHLESINGER
  • 依托单位:
Mechanism of Pore Formation BC12 Family Proteins
  • 批准号:
    7007233
  • 项目类别:
  • 资助金额:
    $26.15万
  • 财政年份:
    2003
  • 负责人:
    PAUL H SCHLESINGER
  • 依托单位:
RUFFLED BORDER CHLORIDE CHANNEL: REGULATION AND CLONING
  • 批准号:
    6287619
  • 项目类别:
  • 资助金额:
    $30.51万
  • 财政年份:
    2001
  • 负责人:
    PAUL H SCHLESINGER
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: